$22.82
0.200.88%
At close: -
$22.82
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Integra Lifesciences Stock Guidance | NASDAQ:IART | Benzinga
Integra Lifesciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | IART | Integra Lifesciences | Q1 | 2025 | $0.40 | $0.45 | $0.56 | $375.00M | $385.00M | $411.71M | Get Alert |
| 02/25/2025 | IART | Integra Lifesciences | FY | 2025 | $2.41 | $2.51 | $2.51 | $1.65B | $1.72B | $1.71B | Get Alert |
| 11/04/2024 | IART | Integra Lifesciences | FY | 2024 | $2.41 | $2.49 | $2.45 | $1.61B | $1.62B | $1.61B | Get Alert |
| 11/04/2024 | IART | Integra Lifesciences | Q4 | 2024 | $0.81 | $0.89 | $0.87 | $441.00M | $451.00M | $448.47M | Get Alert |
| 07/29/2024 | IART | Integra Lifesciences | Q3 | 2024 | $0.36 | $0.44 | $0.85 | $372.00M | $382.00M | $432.11M | Get Alert |
| 07/29/2024 | IART | Integra Lifesciences | FY | 2024 | $2.41 | $2.57 | $3.04 | $1.61B | $1.63B | $1.68B | Get Alert |
| 05/06/2024 | IART | Integra Lifesciences | FY | 2024 | $3.01 | $3.11 | $3.19 | $1.67B | $1.69B | $1.62B | Get Alert |
| 05/06/2024 | IART | Integra Lifesciences | Q2 | 2024 | $0.60 | $0.65 | $0.75 | $411.00M | $416.00M | $395.80M | Get Alert |
| 02/28/2024 | IART | Integra Lifesciences | FY | 2024 | $3.15 | $3.25 | $3.44 | $1.60B | $1.62B | $1.62B | Get Alert |
| 02/28/2024 | IART | Integra Lifesciences | Q1 | 2024 | $0.53 | $0.57 | $0.74 | $360.00M | $365.00M | $380.89M | Get Alert |
| 10/25/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.14 | $3.14 | $1.54B | $1.55B | $1.55B | Get Alert |
| 10/25/2023 | IART | Integra Lifesciences | Q4 | 2023 | $0.89 | $0.93 | $0.78 | $397.00M | $403.00M | $387.12M | Get Alert |
| 07/26/2023 | IART | Integra Lifesciences | Q3 | 2023 | $0.76 | $0.80 | $0.97 | $386.00M | $390.00M | $411.86M | Get Alert |
| 07/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.10 | $3.18 | $3.12 | $1.55B | $1.56B | $1.56B | Get Alert |
| 05/23/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.55 | $0.59 | $0.77 | $372.00M | $376.00M | $398.13M | Get Alert |
| 04/26/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.48 | $1.60B | $1.62B | $1.61B | Get Alert |
| 04/26/2023 | IART | Integra Lifesciences | Q2 | 2023 | $0.75 | $0.79 | $0.85 | $396.00M | $400.00M | $404.78M | Get Alert |
| 02/22/2023 | IART | Integra Lifesciences | FY | 2023 | $3.43 | $3.51 | $3.52 | $1.60B | $1.62B | $1.62B | Get Alert |
| 02/22/2023 | IART | Integra Lifesciences | Q1 | 2023 | $0.72 | $0.76 | $0.79 | $370.00M | $376.00M | $381.72M | Get Alert |
| 01/25/2023 | IART | Integra Lifesciences | FY | 2022 | $3.34 | $3.38 | $3.30 | — | — | — | Get Alert |
| 01/25/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.92 | $0.96 | $0.89 | — | — | — | Get Alert |
| 01/10/2023 | IART | Integra Lifesciences | FY | 2022 | $3.33 | — | $3.30 | $1.56B | $1.56B | $1.56B | Get Alert |
| 01/10/2023 | IART | Integra Lifesciences | Q4 | 2022 | $0.91 | — | $0.89 | $397.00M | $398.00M | $397.50M | Get Alert |
| 10/26/2022 | IART | Integra Lifesciences | FY | 2022 | $3.29 | $3.33 | $3.15 | $1.55B | $1.56B | $1.56B | Get Alert |
| 10/26/2022 | IART | Integra Lifesciences | Q4 | 2022 | $0.87 | $0.91 | $0.88 | $391.00M | $403.00M | $403.50M | Get Alert |
| 08/24/2022 | IART | Integra Lifesciences | FY | 2022 | $3.12 | $3.20 | $3.24 | $1.55B | $1.57B | $1.57B | Get Alert |
| 08/24/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.69 | $0.73 | $0.80 | $374.00M | $382.00M | $387.79M | Get Alert |
| 07/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.21 | $3.29 | $3.31 | $1.56B | $1.57B | $1.59B | Get Alert |
| 07/27/2022 | IART | Integra Lifesciences | Q3 | 2022 | $0.78 | $0.82 | $0.84 | $383.00M | $391.00M | $398.66M | Get Alert |
| 04/27/2022 | IART | Integra Lifesciences | Q2 | 2022 | $0.78 | $0.82 | $0.80 | $392.00M | $400.00M | $394.32M | Get Alert |
| 04/27/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.31 | $1.58M | $1.60B | $1.59B | Get Alert |
| 02/23/2022 | IART | Integra Lifesciences | Q1 | 2022 | $0.67 | $0.71 | $0.73 | $357.00M | $365.00M | $378.50M | Get Alert |
| 02/23/2022 | IART | Integra Lifesciences | FY | 2022 | $3.27 | $3.35 | $3.42 | $1.58B | $1.60B | $1.63B | Get Alert |
| 01/11/2022 | IART | Integra Lifesciences | FY | 2021 | — | — | — | $1.54B | $1.54B | $1.54B | Get Alert |
| 01/11/2022 | IART | Integra Lifesciences | Q4 | 2021 | — | — | — | $404.00M | $406.00M | $403.94M | Get Alert |
| 11/02/2021 | IART | Integra Lifesciences | Q4 | 2021 | $0.82 | $0.86 | $0.81 | $403.00M | $403.00M | $409.65M | Get Alert |
| 11/02/2021 | IART | Integra Lifesciences | FY | 2021 | $3.16 | $3.20 | $3.02 | $1.54B | $1.55B | $1.54B | Get Alert |
| 07/28/2021 | IART | Integra Lifesciences | Q3 | 2021 | $0.71 | $0.74 | $0.74 | $382.00M | $389.00M | $389.25M | Get Alert |
| 07/28/2021 | IART | Integra Lifesciences | FY | 2021 | $2.98 | $3.05 | $2.92 | $1.54B | $1.55B | $1.53B | Get Alert |
| 05/20/2021 | IART | Integra Lifesciences | Q2 | 2021 | $0.67 | $0.67 | $0.66 | $378.00M | $378.00M | $375.03M | Get Alert |
| 05/20/2021 | IART | Integra Lifesciences | FY | 2021 | $2.93 | $2.93 | $2.92 | $1.52B | $1.53B | $1.53B | Get Alert |
| 04/28/2021 | IART | Integra Lifesciences | FY | 2021 | $2.93 | $2.93 | $2.90 | $1.52B | $1.53B | $1.53B | Get Alert |
| 04/28/2021 | IART | Integra Lifesciences | Q2 | 2021 | $0.63 | $0.67 | $0.67 | $372.00M | $378.00M | $370.53M | Get Alert |
| 02/18/2021 | IART | Integra Lifesciences | FY | 2021 | $2.86 | $2.93 | $2.92 | $1.52B | $1.53B | $1.54B | Get Alert |
| 02/18/2021 | IART | Integra Lifesciences | Q1 | 2021 | $0.54 | $0.58 | $0.64 | $345.00M | $355.00M | $359.90M | Get Alert |
| 01/14/2021 | IART | Integra Lifesciences | Q4 | 2020 | — | — | — | $387.00M | $389.00M | $389.05M | Get Alert |
| 01/14/2021 | IART | Integra Lifesciences | FY | 2020 | — | — | — | $1.37B | $1.37B | $1.37B | Get Alert |
| 10/06/2020 | IART | Integra Lifesciences | Q3 | 2020 | — | — | — | $368.00M | $370.00M | $340.39M | Get Alert |
| 07/09/2020 | IART | Integra Lifesciences | Q2 | 2020 | — | — | — | $254.00M | $256.00M | $240.49M | Get Alert |
FAQ
What is the most recent guidance for Integra Lifesciences (IART)?
The most recent guidance for Integra Lifesciences (IART) was reported on February 25, 2025 for Q1 2025. The company provided earnings per share guidance in the range of $0.40 to $0.45, compared to the estimated EPS of $0.56. Additionally, Integra Lifesciences forecasted revenue between $0.38B and $0.39B for the quarter.
Browse guidance and forecast on all stocks.